JPMorgan Large Cap Value Fund Class A

JPMorgan Large Cap Value Fund Class A

OLVAX
JPMorgan Large Cap Value Fund Class AUS flagNASDAQ
- -
USD
- -
- -
No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

APIChatGPT
Sector
Financial Services
Industry
Asset Management
Address
277 Park Avenue New York NY United States of America 10172
IPO Date
Feb 18, 1992
Business
JPMorgan Large Cap Value Fund Class A (OLVAX) is an open-end mutual fund that seeks capital appreciation primarily through investments in a portfolio of U.S. large-cap value stocks, including common stocks and convertible debt and preferred stocks of companies with market capitalizations similar to those in the Russell 1000 Value Index; it normally invests at least 80% of its assets in such equity securities of large companies. The fund employs a research-driven, fundamental analysis approach to identify undervalued securities across sectors, targeting those with underappreciated long-term growth potential, attractive valuations, catalysts for price increases, and temporary mispricings due to market overreactions; its portfolio typically holds approximately 101 securities with a weighted average market cap of $211.45 billion, a forward P/E ratio of 15.87, and sector allocations including financials (17.2%), health care (16.1%), industrials (14.0%), and information technology (14.2%). Share classes include A (OLVAX, with gross expenses of 0.760% and net expenses of 0.690%), C (OLVCX), I (HLQVX), R2 (JLVZX), R3 (OLVTX), R4 (OLVRX), R5 (JLVRX), and R6 (JLVMX); as of September 30, 2025, fund assets stand at $5.37 billion, with top holdings such as Western Digital Corp. (3.8%), Bank of America Corp. (3.7%), Wells Fargo & Co. (3.1%), Alphabet Inc. Class C (3.1%), and Philip Morris International Inc. (2.7%). Launched on March 1, 1991, as part of JPMorgan Trust II, the fund is managed by J.P. Morgan Investment Management Inc., with lead portfolio manager Scott Blasdell (31 years of experience, overseeing since April 2013) and co-manager John Piccard (33 years of experience); the firm is headquartered in New York, New York, with additional operational presence in Boston, Massachusetts. It targets investors seeking large-cap value exposure with incidental current income, exhibiting a beta of 1.10 and Sharpe ratio of 0.82 over three years, and has earned a Morningstar Bronze Medalist Rating as of September 26, 2025, with overall 3-star ratings across periods. Geographically, the fund focuses on U.S. equities (94.76% allocation), with minor non-U.S. stock exposure (4.43%) and cash/short-term investments (0.81%). In recent years, the fund has maintained portfolio continuity under its longstanding management team, with no major manager changes, acquisitions, or structural reorganizations reported; strategic positioning evolved in 2024-2025 to adapt to market dynamics, including increased allocations to technology (up to 14.2%) and communications services amid index rebalances adding names like Alphabet and Meta Platforms to the Russell 1000 Value Index in June 2025, alongside emphasis on less volatile holdings such as REITs (8.6% as of June 2024) during economic uncertainty. Performance remained strong through September 2025, with Class I shares delivering 11.9% annualized returns since Blasdell's tenure began (outperforming the Russell 1000 Value Index's 10.2% and category peers' 9.9%), driven by stock selection in financials and healthcare; year-to-date through September 30, 2025, Class I shares returned 11.09% versus the benchmark's 11.65%, reflecting ongoing fee waivers through October 31, 2025, to cap expenses at 0.690%. The fund continues to benchmark against the Russell 1000 Value Index while aligning with its regulatory benchmark, the Russell 1000 Index.